Zyphars Biopharmaceuticals

Zyphars Biopharmaceuticals is an integrated biopharmaceutical company specializing in the development, manufacturing, and commercialization of high-quality biosimilars and niche biologics. Headquartered in Ahmedabad, India, with corporate operations in the United States, the company focuses on therapeutic areas such as oncology, nephrology, and immunology. Their portfolio includes biosimilar versions of essential monoclonal antibodies, including Rituximab and Bevacizumab, designed to increase patient access to biological therapies in emerging and regulated markets. Zyphars operates state-of-the-art, GMP-compliant manufacturing facilities and offers contract development and manufacturing (CDMO) services. The company is committed to reducing the cost of complex biological treatments while maintaining rigorous international quality standards.